Advanced

Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.

Gerdtham, Ulf LU ; Andersson, L; Ericsson, Asa; Borg, Sixten; Jansson, Sven-Arne; Rönmark, Eva and Lundbäck, Bo (2009) In European Journal of Health Economics 10. p.217-226
Abstract
Chronic obstructive pulmonary disease (COPD) is an increasing public health problem, generating considerable costs. The objective of this study was to identify factors affecting COPD-related costs. A cohort of 179 subjects with COPD was interviewed over the telephone on four occasions about their annual use of COPD-related resources. The data set and explanatory variables were analysed by means of multivariate regression techniques for six different types of cost: societal (or total), direct (health care) and indirect (productivity), and three subcomponents of direct costs-hospitalisation, outpatient and medication. Poor lung function, dyspnoea and asthma were independently associated with higher costs. Poor lung function (severity of... (More)
Chronic obstructive pulmonary disease (COPD) is an increasing public health problem, generating considerable costs. The objective of this study was to identify factors affecting COPD-related costs. A cohort of 179 subjects with COPD was interviewed over the telephone on four occasions about their annual use of COPD-related resources. The data set and explanatory variables were analysed by means of multivariate regression techniques for six different types of cost: societal (or total), direct (health care) and indirect (productivity), and three subcomponents of direct costs-hospitalisation, outpatient and medication. Poor lung function, dyspnoea and asthma were independently associated with higher costs. Poor lung function (severity of COPD) significantly increased all six examined cost types. Dyspnoea (breathing problems) also increased costs, though to a varying extent. The presence of reported asthma increased total, direct, outpatient and medication costs. Poor lung function and, to a lesser extent, extent of dyspnoea and concomitant asthma, were all strongly associated with higher COPD-related costs. Strong efforts should be made to prevent the progression of COPD and its symptoms. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Journal of Health Economics
volume
10
pages
217 - 226
publisher
Springer
external identifiers
  • wos:000266560600011
  • pmid:18853206
  • scopus:63449112295
ISSN
1618-7601
DOI
10.1007/s10198-008-0121-6
language
English
LU publication?
yes
id
da039653-c7b8-4a01-921a-0afe0812ab2b (old id 1262223)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/18853206?dopt=Abstract
date added to LUP
2008-11-03 13:24:11
date last changed
2017-08-20 04:39:29
@article{da039653-c7b8-4a01-921a-0afe0812ab2b,
  abstract     = {Chronic obstructive pulmonary disease (COPD) is an increasing public health problem, generating considerable costs. The objective of this study was to identify factors affecting COPD-related costs. A cohort of 179 subjects with COPD was interviewed over the telephone on four occasions about their annual use of COPD-related resources. The data set and explanatory variables were analysed by means of multivariate regression techniques for six different types of cost: societal (or total), direct (health care) and indirect (productivity), and three subcomponents of direct costs-hospitalisation, outpatient and medication. Poor lung function, dyspnoea and asthma were independently associated with higher costs. Poor lung function (severity of COPD) significantly increased all six examined cost types. Dyspnoea (breathing problems) also increased costs, though to a varying extent. The presence of reported asthma increased total, direct, outpatient and medication costs. Poor lung function and, to a lesser extent, extent of dyspnoea and concomitant asthma, were all strongly associated with higher COPD-related costs. Strong efforts should be made to prevent the progression of COPD and its symptoms.},
  author       = {Gerdtham, Ulf and Andersson, L and Ericsson, Asa and Borg, Sixten and Jansson, Sven-Arne and Rönmark, Eva and Lundbäck, Bo},
  issn         = {1618-7601},
  language     = {eng},
  pages        = {217--226},
  publisher    = {Springer},
  series       = {European Journal of Health Economics},
  title        = {Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.},
  url          = {http://dx.doi.org/10.1007/s10198-008-0121-6},
  volume       = {10},
  year         = {2009},
}